PMID- 25289111
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20211021
IS  - 1792-1074 (Print)
IS  - 1792-1082 (Electronic)
IS  - 1792-1074 (Linking)
VI  - 8
IP  - 5
DP  - 2014 Nov
TI  - ANXA9 gene expression in colorectal cancer: A novel marker for prognosis.
PG  - 2313-2317
AB  - Annexin A9 (ANXA9) is involved with the interaction with membrane phospholipids 
      in a Ca(2+)-dependent manner. A previous study has shown that ANXA9 expression is 
      associated with bone metastasis in breast cancer, whereas its significance in 
      colorectal cancer (CRC) is unknown. The present study was comprised of 100 
      patients who underwent surgery for CRC. The correlation between gene expression 
      and the clinical parameters of the patients was assessed. Patients with high 
      ANXA9 expression were statistically susceptible to a relatively worse prognosis, 
      and those with low ANXA9 expression showed improved overall survival compared 
      with those with high expression. In conclusion, the present data suggests that 
      ANXA9 expression is a prognostic factor in CRC patients.
FAU - Miyoshi, Norikatsu
AU  - Miyoshi N
AD  - Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular 
      Diseases, Osaka, Osaka 537-8511, Japan.
FAU - Yamamoto, Hirofumi
AU  - Yamamoto H
AD  - Department of Gastroenterological Surgery, Osaka University Graduate School of 
      Medicine, Suita, Osaka 565-0871, Japan.
FAU - Mimori, Koshi
AU  - Mimori K
AD  - Department of Molecular and Cellular Biology, Division of Molecular and Surgical 
      Oncology, Medical Institute of Bioregulation, Kyushu University, Beppu, Ohita 
      874-0838, Japan.
FAU - Yamashita, Shinya
AU  - Yamashita S
AD  - Department of Surgery, National Hospital Organization Kure Medical Center, Kure, 
      Hiroshima 737-0023, Japan.
FAU - Miyazaki, Susumu
AU  - Miyazaki S
AD  - Department of Surgery, Osaka General Medical Center, Osaka, Osaka 558-8558, 
      Japan.
FAU - Nakagawa, Sumiko
AU  - Nakagawa S
AD  - Department of Gastroenterological Surgery, Osaka University Graduate School of 
      Medicine, Suita, Osaka 565-0871, Japan.
FAU - Ishii, Hideshi
AU  - Ishii H
AD  - Department of Frontier Science for Cancer and Chemotherapy, Osaka University, 
      Suita, Osaka 565-0871, Japan.
FAU - Noura, Shingo
AU  - Noura S
AD  - Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular 
      Diseases, Osaka, Osaka 537-8511, Japan.
FAU - Ohue, Masayuki
AU  - Ohue M
AD  - Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular 
      Diseases, Osaka, Osaka 537-8511, Japan.
FAU - Yano, Masahiko
AU  - Yano M
AD  - Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular 
      Diseases, Osaka, Osaka 537-8511, Japan.
FAU - Doki, Yuichiro
AU  - Doki Y
AD  - Department of Surgery, National Hospital Organization Kure Medical Center, Kure, 
      Hiroshima 737-0023, Japan.
FAU - Mori, Masaki
AU  - Mori M
AD  - Department of Surgery, National Hospital Organization Kure Medical Center, Kure, 
      Hiroshima 737-0023, Japan.
LA  - eng
PT  - Journal Article
DEP - 20140825
PL  - Greece
TA  - Oncol Lett
JT  - Oncology letters
JID - 101531236
PMC - PMC4186559
OTO - NOTNLM
OT  - ANXA9
OT  - colorectal cancer
OT  - prognosis
EDAT- 2014/10/08 06:00
MHDA- 2014/10/08 06:01
PMCR- 2014/08/25
CRDT- 2014/10/08 06:00
PHST- 2014/02/19 00:00 [received]
PHST- 2014/08/01 00:00 [accepted]
PHST- 2014/10/08 06:00 [entrez]
PHST- 2014/10/08 06:00 [pubmed]
PHST- 2014/10/08 06:01 [medline]
PHST- 2014/08/25 00:00 [pmc-release]
AID - ol-08-05-2313 [pii]
AID - 10.3892/ol.2014.2477 [doi]
PST - ppublish
SO  - Oncol Lett. 2014 Nov;8(5):2313-2317. doi: 10.3892/ol.2014.2477. Epub 2014 Aug 25.